Key statistics
On Friday, Karolinska Development AB (2I9:DEU) closed at 0.10, 31.58% above the 52 week low of 0.076 set on Nov 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.10 |
---|---|
High | 0.108 |
Low | 0.08 |
Bid | 0.0922 |
Offer | 0.109 |
Previous close | 0.10 |
Average volume | 0.00 |
---|---|
Shares outstanding | 267.52m |
Free float | 95.37m |
P/E (TTM) | -- |
Market cap | 312.47m SEK |
EPS (TTM) | -0.0209 SEK |
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Announcements
- Karolinska Development’s portfolio company BOOST Pharma successfully completes pre-IND meeting with FDA and receives second tranche of investment
- Karolinska Developments portföljbolag BOOST Pharma har genomfört ett framgångsrikt FDA-möte och erhåller andra delen av tidigare avtalad investering
- Karolinska Developments portföljbolag SVF Vaccines presenterar positiva data från en fas 1-studie med bolagets universella vaccin mot covid-19
- Karolinska Development’s portfolio company SVF Vaccines announces positive data from a phase 1 study of its universal Covid-19 vaccine
- Karolinska Development’s portfolio company Umecrine Cognition presents new preclinical Parkinson’s data on golexanolone at the scientific conference, INBC 2024
- Karolinska Developments portföljbolag Umecrine Cognition presenterar nya prekliniska Parkinsondata för golexanolon på den vetenskapliga konferensen INBC 2024
- Aktieägarna i Karolinska Development AB (publ) kallas till extra bolagsstämma
- Notice of Extraordinary General Meeting in Karolinska Development AB (publ)
- Karolinska Development divests its holding in the Danish dermatology company Henlez
- Karolinska Development avyttrar hela innehavet i det danska dermatologibolaget Henlez
More ▼